Maxi Nicotine 4 mg/1 (Nicotine Polacrilex LOZENGE) 4 mg/1

Maxi Nicotine 4 mg/1 lozenges are designed to help manage nicotine cravings. These oral lozenges provide a controlled release of nicotine to support smoking cessation efforts.

Strength

4 mg/1

Pack Size

3 BOTTLE, PLASTIC in 1 BOX (0536-1338-09) / 24 LOZENGE in 1 BOTTLE, PLASTIC

Manufacturer / TM Owner

Rugby Laboratories, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Maxi Nicotine 4 mg/1 lozenges are used as an aid to help people quit smoking. They work by delivering nicotine through the oral mucosa, which can help reduce withdrawal symptoms and cravings. This product is intended for adults who are at least 18 years old and smoke 10 or more cigarettes a day.

Side Effects

When used as directed, Maxi Nicotine 4 mg/1 lozenges can help alleviate the urge to smoke by providing a steady release of nicotine. Some users may experience common effects such as mouth or throat irritation, nausea, or hiccups. These effects are generally mild and temporary.

Precautions & Warnings

Maxi Nicotine 4 mg/1 lozenges should be used with caution. They are not suitable for everyone, especially those with certain medical conditions or those who are pregnant or breastfeeding. Always follow the instructions provided and consult a healthcare professional if you have any concerns.

Avoid Interactions

Maxi Nicotine 4 mg/1 lozenges may interact with other medications or substances. It is important to avoid smoking while using these lozenges, as smoking can increase the amount of nicotine in your system. Additionally, be cautious when consuming caffeine or other stimulants, as they may enhance the effects of nicotine.

Frequently Asked Questions

Maxi Nicotine 4 mg/1 lozenges are used to help manage nicotine cravings and support smoking cessation efforts.

These lozenges deliver nicotine through the oral mucosa, which can help reduce withdrawal symptoms and cravings associated with quitting smoking.

Common effects may include mouth or throat irritation, nausea, or hiccups. These effects are generally mild and temporary.

Maxi Nicotine 4 mg/1 lozenges are not recommended for use during pregnancy. Consult a healthcare professional for personalized advice.

Store Maxi Nicotine 4 mg/1 lozenges at room temperature, away from moisture and heat. Keep them out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.